270Surgical Ltd.

www.270surgical.com

Formerly Mitos Medical

High-Tech Company

TECH VERTICALS

Endoscopy, Healthtech, Laparoscopy, Life Sciences, Machine Vision, Medical Devices, MedTech, Robotics

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2016
Number of Employees	30
Employees in Israel	26
Reg. Number:	abCDe

DESCRIPTION

270Surgical is a developer of a specialty laparoscopic system, designed to resolve the problem of restricted field-of-view in surgeries. The company's system is a surround vision technology that provides wide cavity visualization to overcome challenges including restricted view, lens fogging and surgical smokes, enabling surgeons to be efficient and safe in the operating room.

TECHNOLOGY

SURROUNDSCOPE™ is a pioneering laparoscopic system, enabling surgeons a new, safer and more efficient way to operate. The 270 ̊ wide field of view technology reduces 'off-screen' injuries, provides surgeons better visibility and substantially improves patient outcomes.

Products and Phases

Product	Phase
SurroundScope™	FDA Approved
Innovative Medical Vision Solution.

	TARGET MARKETS
	Surgeons.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Netanya, Israel

Address	4 Arie Regev St.
POB	8414
City	Netanya
Country	Israel
Zip	4250212

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Dallas, United States

Address	1920 Mckinney Ave 8th Floor
City	Dallas
State/Province	TX
Country	United States
Zip	75201

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Avi Levy	CEO & Founder	EndoChoice Innovation Center (President of Technology)
Dr. Shirley Shapira	VP, Clinical Affairs	MetaCure (VP Clinical & Regulation, Motus GI)
Mr. Moshiko Levi	VP, R&D
Dr. Liad Nishlis	VP, Business Development

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Managing General Partner, Agate Medical Investments
abC Defghij	Board Member	CEO & Founder, 270 Surrgical
abC Defghij	Board Member	VP, R&D, 270 Surgical
abC Defghij	Board Member	Former President - Teva Japan, Teva Pharmaceuticals

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round - Extended

May. 01, 2022

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Jun. 15, 2020

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe

First Round

Nov. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Investment Company	abCDe

Seed

Jun. 01, 2017

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jan. 08, 2019

R&D

abCDe

Co-op with FiberTech Medical (U.S.)

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jun. 07, 2023

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	General Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe